Editor's Corner
![]()
Today I'm reporting live from BIO, the annual conference of the Biotechnology Industry Organization. The show is now fully underway this morning as 18,000 biotech players from around the globe arrive in Philadelphia. This is a chance for hundreds of biotech companies to tout their progress and discuss stem cell research, the growing alliance between biotech companies and big pharma, and what India and China mean for the future of drug development. FierceBiotech will put the spotlight on emerging private biotech companies in this evening's announcement of the Fierce 15, with the special issue coming out tomorrow for all readers. - John Carroll
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


